NCT00048334View on ClinicalTrials.gov

Depsipeptide to Treat Thyroid and Other Advanced Cancers

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 26, 2002

Primary Completion Date

April 1, 2010

Study Completion Date

April 1, 2010

Conditions
Neoplasms
Interventions
DRUG

Depsipeptide, FR901228, FK228

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00048334 - Depsipeptide to Treat Thyroid and Other Advanced Cancers | Biotech Hunter | Biotech Hunter